Is lamivudine dolutegravir tablets a blocking drug?

Lamivudine dolutegravir tablets(Dovito) is a drug that blocks HIV; Lamivudine dolutegravir tablets are indicated for the treatment of adults with no history of antiretroviral treatmentHIV-1A complete regimen of viral infection, or as a replacement for virological suppression in a stable antiretroviral regimen (HIV-1 RNAless than50copies/mL) of existing antiretroviral regimens with no history of treatment failure and no known alternatives associated with resistance to individual components of lamivudine dolutegravir tablets.

Lamivudine dolutegravir tablets are a fixed combination antiretroviral drug containing dolutegravir and lamivudine. Dolutegravir is an AIDS agency. The drug binds to the active site of HIVintegrase and blocks the strand transfer step of retroviral DNA integration, which is critical for HIV replication. Actively against HIV-1; also has in vitro activity against 2 HIV (HIV-2). Lamivudine is an HIVNRTI. A prodrug that is inactive before being converted intracellularly to the active 5′-triphosphate metabolite (lamivudine triphosphate). After conversion, it acts as a reverse transcriptase inhibitor by DNA chain termination upon incorporation of nucleotide analogs. Actively opposeHIV-1, also actively opposeHBV. HIV-1is resistant to dolutegravir produced in vitro and has emerged in HIVIn infected patients; amino acid substitutionG118R reduces susceptibility to dolutegravir in vitro by 10 times. HIV-1 produced in vitro that is resistant to lamivudine, HIV already receiving lamivudine-containing treatmentOccurs in infected patients; HIV-1Resistance to lamivudine often involves amino acid substitutions M184V or M184I. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0